|Articles|January 1, 2010

Thank you for completing our Digital Media Survey

Thank you

Please click here to return to the Home Page

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

© JHVEPhoto - © JHVEPhoto - stock.adobe.com

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ByAndy Studna

December 4th 2025

Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER

ByNicholas Jacobus

December 4th 2025

FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

ByNicholas Jacobus

December 4th 2025

FDA Appoints Tracy Beth Høeg as Acting Director of CDER

ByNicholas Jacobus

December 4th 2025

Image Credit: Adobe Stock Images/ktsdesign

Five Steps for Successful CGT Commercialization Through Health Systems Partnerships

ByKevin Chinn and Louis Cicchini, PhD

December 4th 2025

Thank you for completing our Digital Media Survey

Newsletter

Related Content

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER

FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

FDA Appoints Tracy Beth Høeg as Acting Director of CDER

Five Steps for Successful CGT Commercialization Through Health Systems Partnerships

Trending on PharmExec

FDA Appoints Tracy Beth Høeg as Acting Director of CDER

Report: Richard Pazdur Out as Director of CDER

Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy

Reshaping Kidney Care: Q&A with Stylianos Sarrigiannidis

Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients